在个性化瘤学中使用新抗原驱动的癌症疫苗:进展,障碍和转化前景
N Prabhu1, V Rajinikanth1, Mathiyazhagan Narayanan2
1Department of Biotechnology, Research and Innovations, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, SIMATS, Thandalam, Chennai, 602 105, Tamil Nadu, India.
由瘤突变衍生的新抗原癌症疫苗提供个性化免疫疗法. 虽然在早期试验中很有希望,但瘤异质性和预测准确性等挑战需要解决,以便更广泛地使用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 新抗原是瘤特异性突变,非常适合向癌症疫苗.
- 个性化瘤学利用新抗原进行量身定制的免疫治疗.
- 进步使得迅速的鉴定和疫苗开发成为可能.
研究的目的:
- 综合分析新抗原疫苗生物学,检测和平台.
- 评估临床结果,组合策略和限制.
- 探索未来的机遇,包括人工智能和大规模生产.
主要方法:
- 对下一代测序,免疫组学和计算表位预测的审查.
- 对各种疫苗平台 (,mRNA,DNA,树突细胞) 的分析.
- 对临床试验数据和免疫检查点抑制剂组合的评估.
主要成果:
- 新抗原疫苗在试验中显示出安全性,实用性和免疫性.
- 观察到有前途的治疗反应,特别是免疫检查点抑制剂.
- 挑战包括瘤异质性,预测准确性和制造.
结论:
- 新抗原疫苗是个性化癌症免疫疗法的重大突破.
- 解决挑战对于广泛的临床应用至关重要.
- 未来的方向包括人工智能集成和可扩展的疫苗生产.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
